Joanna Hauser Selected Research

Nortriptyline (Aventyl)

1/2019	Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder.
1/2019	Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
10/2018	Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
1/2016	Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
12/2014	An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
4/2011	Changes in body weight during pharmacological treatment of depression.
12/2010	Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
6/2010	History of suicide attempts among patients with depression in the GENDEP project.
11/2009	Body weight as a predictor of antidepressant efficacy in the GENDEP project.
11/2009	Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanna Hauser Research Topics

Disease

36	Bipolar Disorder (Manic Depressive Psychosis) 07/2022 - 01/2002
32	Schizophrenia (Dementia Praecox) 07/2022 - 01/2002
13	Major Depressive Disorder (Major Depressive Disorders) 04/2022 - 11/2009
10	Mood Disorders (Mood Disorder) 01/2021 - 01/2002
6	Genetic Risk Score 07/2022 - 01/2017
6	Mental Disorders (Mental Disorder) 01/2021 - 06/2006
6	Anorexia Nervosa 01/2019 - 01/2003
6	Inflammation (Inflammations) 10/2018 - 06/2007
5	Depressive Disorder (Melancholia) 04/2011 - 06/2005
3	Drug-Related Side Effects and Adverse Reactions 11/2021 - 09/2009
3	Weight Gain 07/2011 - 09/2009
2	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2011 - 09/2009
2	Body Weight (Weight, Body) 04/2011 - 11/2009
2	Neoplasms (Cancer) 03/2011 - 01/2009
2	Heart Diseases (Heart Disease) 03/2011 - 01/2009
2	Neurobehavioral Manifestations 12/2010 - 03/2009
2	Asthma (Bronchial Asthma) 01/2008 - 06/2007
2	Psychotic Disorders (Schizoaffective Disorder) 02/2006 - 01/2006
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2006 - 01/2006
1	Anhedonia 01/2018
1	Neuralgia (Stump Neuralgia) 01/2017
1	Dizziness (Lightheadedness) 07/2015
1	Pain (Aches) 01/2015
1	Disease Progression 01/2013
1	Anorexia 01/2013
1	Cognitive Dysfunction 01/2013
1	Rheumatoid Arthritis 01/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2012
1	Hyperprolactinemia 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Weight Loss (Weight Reduction) 04/2011
1	Anxiety Disorders (Anxiety Disorder) 01/2010
1	Obesity 11/2009
1	Overweight 11/2009
1	Constipation 09/2009
1	Respiratory Hypersensitivity 06/2007
1	Hypersensitivity (Allergy) 06/2007
1	Alcoholism (Alcohol Abuse) 03/2007

Drug/Important Bio-Agent (IBA)

18	LithiumIBA 07/2022 - 11/2005
16	Antidepressive Agents (Antidepressants)IBA 04/2022 - 09/2009
13	Nortriptyline (Aventyl)FDA LinkGeneric 01/2019 - 03/2009
13	Escitalopram FDA Link 01/2019 - 03/2009
9	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 10/2004
5	Pharmaceutical PreparationsIBA 11/2021 - 07/2011
4	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2014 - 06/2006
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2013 - 01/2011
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 03/2010 - 05/2003
3	Biological ProductsIBA 01/2021 - 01/2018
3	C-Reactive ProteinIBA 10/2018 - 12/2014
3	Biomarkers (Surrogate Marker)IBA 07/2017 - 12/2014
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2014 - 01/2002
3	EnzymesIBA 01/2014 - 01/2003
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2011 - 01/2009
3	Phosphotransferases (Kinase)IBA 01/2009 - 06/2007
3	Dopamine Receptors (Dopamine Receptor)IBA 03/2007 - 01/2006
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2019 - 04/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019 - 12/2014
2	MicroRNAs (MicroRNA)IBA 01/2018 - 07/2017
2	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 01/2012
2	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 04/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 12/2004
2	Immunoglobulin E (IgE)IBA 01/2008 - 06/2007
2	Lithium Carbonate (Eskalith)FDA LinkGeneric 09/2007 - 01/2005
2	Folic Acid (Vitamin M)FDA LinkGeneric 06/2007 - 01/2007
2	Dopamine (Intropin)FDA LinkGeneric 03/2007 - 06/2005
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2006 - 05/2002
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2006 - 01/2006
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2006 - 12/2002
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 04/2003 - 01/2003
2	Neurotransmitter Agents (Neurotransmitter)IBA 04/2003 - 01/2002
1	FurinIBA 01/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021
1	LipidsIBA 01/2019
1	AntigensIBA 01/2018
1	Small Untranslated RNAIBA 07/2017
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2017
1	CalciumIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2016
1	tacrolimus binding protein 5IBA 01/2014
1	HomocysteineIBA 01/2014
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2013
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 11/2013
1	Hormones (Hormone)IBA 11/2013
1	Nerve Growth Factors (Neurotrophins)IBA 01/2013
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2013
1	SolutionsIBA 07/2012
1	ProlactinIBA 01/2012
1	NeurocanIBA 03/2011
1	Tyrosine (L-Tyrosine)FDA Link 01/2008
1	10-formyltetrahydropteroylglutamic acidIBA 06/2007
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 06/2007
1	Ligases (Synthetase)IBA 06/2007
1	Oxidoreductases (Dehydrogenase)IBA 06/2007
1	5,10-methylenetetrahydrofolic acidIBA 06/2007
1	Methenyltetrahydrofolate CyclohydrolaseIBA 06/2007
1	CarbonIBA 01/2007

Therapy/Procedure

4	Therapeutics 11/2021 - 01/2016